| 1 |
ResMed Inc
RMD · USA
|
$31B |
99/100
Exzellent
|
51/100 |
20.4%low 15.3% |
10 yr+ |
Net cash |
58% |
ResMed 长期所有者视角研究28. Mai 2026 · 观察 |
FY2025 |
| 2 |
Cadence Design Systems Inc
CDNS · USA
|
$94B |
97/100
Exzellent
|
51/100 |
27.5%low 20.3% |
10 yr+ |
Net cash |
88% |
Cadence Design Systems 深度价值投资分析21. Mai 2026 · 观察 |
FY2025 |
| 3 |
Check Point Software Technologies Ltd
CHKP · USA
|
$13B |
97/100
Exzellent
|
42/100 |
26.1%low 20.8% |
10 yr+ |
Net cash |
88% |
Check Point: A High-Margin Cash Engine Whose Growth Gap Is Not Yet in the Price16. August 2026 · Watch |
FY2025 |
| 4 |
AJ Bell plc
AJB · LSE
|
$2.9B |
97/100
Exzellent
|
49/100 |
35.9%low 24.8% |
10 yr+ |
Net cash |
100% |
AJ Bell: Reconstructed FY2025 Client-Cash Interest of £136.5m Nearly Equals £137.8m Group PBT, H1 Revenue Margin Expanded to 33.4 Basis Points Instead of Compressing, and £6.18 Leaves No Margin of Safety16. August 2026 · Hold |
FY2025 |
| 5 |
Adobe Systems Incorporated
ADBE · USA
|
$100B |
96/100
Exzellent
|
48/100 |
33.0%low 15.7% |
10 yr+ |
0.0× |
87% |
Adobe 长期企业所有者视角投资研究21. Mai 2026 · 谨慎买入 |
FY2025 |
| 6 |
Monster Beverage Corp
MNST · USA
|
$94B |
96/100
Exzellent
|
49/100 |
23.0%low 17.0% |
10 yr+ |
Net cash |
58% |
Monster Beverage Corporation 深度价值投资分析22. Mai 2026 · 观察 |
FY2025 |
| 7 |
F5 Networks Inc
FFIV · USA
|
$23B |
96/100
Exzellent
|
45/100 |
21.7%low 13.0% |
10 yr+ |
Net cash |
82% |
F5 深度价值投资研究29. Mai 2026 · 观察 |
FY2025 |
| 8 |
Federated Investors Inc B
FHI · USA
|
$4.6B |
96/100
Exzellent
|
40/100 |
28.6%low 22.9% |
10 yr+ |
Net cash |
68% |
Federated Hermes: A Durable Cash Franchise Priced for Today's Rates, Not the Next Zero16. August 2026 · Hold |
FY2025 |
| 9 |
Visa Inc. Class A
V · USA
|
$684B |
95/100
Exzellent
|
49/100 |
35.7%low 18.2% |
10 yr+ |
0.1× |
81% |
Visa Inc. 长期企业所有者视角研究25. Mai 2026 · 观察 |
FY2025 |
| 10 |
Garmin Ltd
GRMN · USA
|
$57B |
95/100
Exzellent
|
47/100 |
17.6%low 14.9% |
10 yr+ |
Net cash |
58% |
Garmin Ltd. 深度价值投资研究27. Mai 2026 · 观察 |
FY2025 |
| 11 |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
300760 · Shenzhen
|
$27B |
95/100
Exzellent
|
52/100 |
30.1%low 21.4% |
10 yr+ |
Net cash |
64% |
Mindray Bio-Medical: The Transition Is Real, But So Is the Price Tag19. Juli 2026 · Hold |
FY2025 |
| 12 |
Snap-On Inc
SNA · USA
|
$21B |
95/100
Exzellent
|
45/100 |
19.5%low 16.4% |
10 yr+ |
Net cash |
50% |
Snap-on 深度价值投资研究30. Mai 2026 · 观察 |
FY2025 |
| 13 |
Manhattan Associates Inc
MANH · USA
|
$11B |
95/100
Exzellent
|
53/100 |
56.1%low 39.9% |
10 yr+ |
Net cash |
54% |
Manhattan Associates: 26% Cloud Growth Sits Inside 9.3% Total Revenue Growth, Existing Customers Supplied 75% of Q2 New Cloud Contract Value, and 40x SBC-Adjusted Owner Earnings Leaves No Margin of Safety16. August 2026 · Hold |
FY2025 |
| 14 |
Jack Henry & Associates Inc
JKHY · USA
|
$11B |
95/100
Exzellent
|
45/100 |
21.7%low 15.4% |
10 yr+ |
Net cash |
42% |
Jack Henry & Associates 深度价值投资分析31. Mai 2026 · 观察 |
FY2025 |
| 15 |
Paycom Software, Inc.
PAYC · USA
|
$7.6B |
95/100
Exzellent
|
47/100 |
28.8%low 21.9% |
10 yr+ |
Net cash |
84% |
Paycom Software: Has Automation Repaired the Growth Engine, and Is That Already Priced?7. August 2026 · Hold |
FY2025 |
| 16 |
WD-40 Company
WDFC · USA
|
$3.0B |
95/100
Exzellent
|
43/100 |
36.0%low 30.2% |
10 yr+ |
0.1× |
54% |
WD-40 Company: A Seven-Decade Brand, a Borrowed Quarter, and No Margin of Safety17. August 2026 · Hold |
FY2025 |
| 17 |
National Beverage Corp
FIZZ · USA
|
$3.0B |
95/100
Exzellent
|
39/100 |
41.0%low 28.7% |
10 yr+ |
Net cash |
37% |
National Beverage: A Cash-Rich LaCroix Franchise Where Price, Not Volume, Carried the Year17. August 2026 · Hold |
FY2026 |
| 18 |
Automatic Data Processing Inc
ADP · USA
|
$106B |
94/100
Exzellent
|
48/100 |
52.2%low 42.5% |
10 yr+ |
0.2× |
47% |
ADP 长期所有者视角价值分析21. Mai 2026 · 观察 |
FY2026 |
| 19 |
Intuit Inc
INTU · USA
|
$86B |
94/100
Exzellent
|
50/100 |
33.7%low 12.6% |
10 yr+ |
0.1× |
82% |
Intuit Inc. 深度价值分析22. Mai 2026 · 观察 |
FY2025 |
| 20 |
Fastenal Company
FAST · USA
|
$55B |
94/100
Exzellent
|
45/100 |
31.0%low 25.8% |
10 yr+ |
0.0× |
47% |
Fastenal Company 深度价值研究22. Mai 2026 · 观察 |
FY2025 |
| 21 |
Hansoh Pharmaceutical Group Co Ltd
3692 · Hongkong
|
$25B |
94/100
Exzellent
|
53/100 |
26.3%low 11.4% |
10 yr+ |
Net cash |
91% |
Hansoh Pharmaceutical: One Molecule, One Royalty Book, and a Price That Already Pays for Both17. August 2026 · Hold |
FY2025 |
| 22 |
Games Workshop Group PLC
GAW · LSE
|
$8.0B |
94/100
Exzellent
|
42/100 |
57.4%low 48.6% |
10 yr+ |
Net cash |
70% |
Games Workshop: An Exceptional Warhammer Compounder, Priced for Continued Excellence26. Juni 2026 · Hold |
FY2026 |
| 23 |
Exponent Inc
EXPO · USA
|
$3.2B |
94/100
Exzellent
|
46/100 |
26.7%low 22.8% |
10 yr+ |
Net cash |
60% |
Exponent: A PhD-Dense Expert Franchise Whose Reacceleration Is Real but Already Priced17. August 2026 · Hold |
FY2025 |
| 24 |
KLA Corporation
KLAC · USA
|
$239B |
93/100
Exzellent
|
52/100 |
55.9%low 44.2% |
10 yr+ |
0.2× |
61% |
KLA Corporation 深度价值投资分析22. Mai 2026 · 观察 |
FY2026 |
| 25 |
Kweichow Moutai Co Ltd
600519 · Shanghai
|
$236B |
93/100
Exzellent
|
48/100 |
30.8%low 22.9% |
10 yr+ |
Net cash |
90% |
贵州茅台长期企业所有者视角研究21. Mai 2026 · 观察 |
FY2025 |
| 26 |
Hermes International SCA
RMS · Paris
|
$173B |
93/100
Exzellent
|
52/100 |
24.9%low 18.8% |
10 yr+ |
Net cash |
68% |
Hermès International SCA: A 41% Operating Margin Meets 6.1% Constant-Currency Growth, and EUR 1,475 Sits 18-31% Above the Conservative Value8. September 2026 · Hold |
FY2025 |
| 27 |
Accenture plc
ACN · USA
|
$102B |
93/100
Exzellent
|
47/100 |
33.4%low 24.6% |
10 yr+ |
Net cash |
31% |
Accenture 长期所有者视角研究23. Mai 2026 · 谨慎买入 |
FY2025 |
| 28 |
Infosys Ltd ADR
INFY · USA
|
$51B |
93/100
Exzellent
|
42/100 |
27.5%low 20.1% |
10 yr+ |
Net cash |
33% |
Infosys 深度价值投资研究20. Mai 2026 · 观察 |
FY2026 |
| 29 |
Corpay Inc
CPAY · USA
|
$25B |
93/100
Exzellent
|
52/100 |
26.1%low 14.7% |
10 yr+ |
0.3× |
78% |
Corpay 价值投资深度研究29. Mai 2026 · 观察 |
FY2025 |
| 30 |
ASML Holding NV ADR
ASML · USA
|
$626B |
92/100
Exzellent
|
55/100 |
36.5%low 15.9% |
10 yr+ |
Net cash |
49% |
ASML Holding N.V.: A €43–45bn Guidance Reset, 38x Forward Earnings, and No Conservative Margin of Safety11. August 2026 · Hold |
FY2025 |
| 31 |
Applied Materials Inc
AMAT · USA
|
$403B |
92/100
Exzellent
|
48/100 |
38.9%low 23.8% |
10 yr+ |
Net cash |
46% |
Applied Materials 深度价值投资研究21. Mai 2026 · 观察 |
FY2025 |
| 32 |
Roche Holding AG
ROG · SW
|
$326B |
92/100
Exzellent
|
36/100 |
39.6%low 26.1% |
10 yr+ |
0.5× |
72% |
罗氏(Roche)横纵框架深度研究:熬过专利悬崖的诊断+制药巨头,公道价格撞上争议增长5. Juni 2026 · 持有 |
FY2025 |
| 33 |
NetEase Inc
NTES · USA
|
$85B |
92/100
Exzellent
|
50/100 |
21.6%low 13.4% |
10 yr+ |
Net cash |
57% |
网易 NetEase 深度研究15. Juni 2026 · 持有 |
FY2025 |
| 34 |
Nike Inc
NKE · USA
|
$62B |
92/100
Exzellent
|
43/100 |
33.5%low 19.7% |
10 yr+ |
0.1× |
44% |
NIKE 深度价值投资分析26. Mai 2026 · 观察 |
FY2026 |
| 35 |
IDEXX Laboratories Inc
IDXX · USA
|
$44B |
92/100
Exzellent
|
47/100 |
58.9%low 55.7% |
10 yr+ |
0.6× |
58% |
IDEXX Laboratories 深度价值研究22. Mai 2026 · 观察 |
FY2025 |
| 36 |
ANTA Sports Products Ltd
2020 · Hongkong
|
$28B |
92/100
Exzellent
|
55/100 |
23.7%low 19.9% |
10 yr+ |
Net cash |
57% |
ANTA Sports: Other Brands Grew 59.2% While the Core Brand Managed 3.7%, and at HKD 74.50 the Shares Already Sit Above the HKD 68 Conservative Sum-of-the-Parts7. August 2026 · Hold |
FY2025 |
| 37 |
Lululemon Athletica Inc.
LULU · USA
|
$13B |
92/100
Exzellent
|
46/100 |
30.2%low 16.2% |
10 yr+ |
Net cash |
56% |
Lululemon Athletica 深度价值投资研究30. Mai 2026 · 观察 |
FY2026 |
| 38 |
Brown-Forman Corporation
BF-B · USA
|
$13B |
92/100
Exzellent
|
44/100 |
35.3%low 17.8% |
10 yr+ |
0.5× |
62% |
Brown-Forman 深度价值分析31. Mai 2026 · 观察 |
FY2026 |
| 39 |
FactSet Research Systems Inc
FDS · USA
|
$9.4B |
92/100
Exzellent
|
45/100 |
40.4%low 27.3% |
10 yr+ |
0.6× |
53% |
FactSet Research Systems 价值投资深度研究31. Mai 2026 · 谨慎买入 |
FY2025 |
| 40 |
Microsoft Corporation
MSFT · USA
|
$3.5T |
91/100
Exzellent
|
67/100 |
34.6%low 20.0% |
10 yr+ |
0.1× |
68% |
Microsoft: Azure Demand Is Real and the Moat Is Intact, but 393 USD Already Prices a Clean Conversion of the 190 Billion USD Capex Wave29. Juli 2026 · Hold |
FY2026 |
| 41 |
Edwards Lifesciences Corp
EW · USA
|
$50B |
91/100
Exzellent
|
48/100 |
23.4%low 10.4% |
10 yr+ |
Net cash |
76% |
Edwards Lifesciences 深度价值研究27. Mai 2026 · 观察 |
FY2025 |
| 42 |
Paychex Inc
PAYX · USA
|
$42B |
91/100
Exzellent
|
46/100 |
42.6%low 37.2% |
10 yr+ |
0.9× |
71% |
Paychex 投资研究报告22. Mai 2026 · 观察 |
FY2026 |
| 43 |
Copart Inc
CPRT · USA
|
$27B |
91/100
Exzellent
|
49/100 |
26.4%low 16.9% |
10 yr+ |
Net cash |
45% |
Copart 深度价值投资分析21. Mai 2026 · 观察 |
FY2025 |
| 44 |
Smith AO Corporation
AOS · USA
|
$8.2B |
91/100
Exzellent
|
41/100 |
23.4%low 13.5% |
10 yr+ |
Net cash |
39% |
A. O. Smith 热水器与水处理深度研究23. Mai 2026 · 观察 |
FY2025 |
| 45 |
Lam Research Corp
LRCX · USA
|
$367B |
90/100
Exzellent
|
49/100 |
48.3%low 24.3% |
10 yr+ |
Net cash |
47% |
Lam Research 长期企业所有者视角研究22. Mai 2026 · 观察 |
FY2026 |
| 46 |
Cintas Corporation
CTAS · USA
|
$82B |
90/100
Exzellent
|
46/100 |
32.2%low 20.9% |
10 yr+ |
0.5× |
47% |
Cintas Corporation 长期所有者视角研究22. Mai 2026 · 观察 |
FY2026 |
| 47 |
Electronic Arts Inc
EA · USA
|
$53B |
90/100
Exzellent
|
42/100 |
18.6%low 10.3% |
10 yr+ |
Net cash |
76% |
Electronic Arts 价值投资深度研究22. Mai 2026 · 观察 |
FY2026 |
| 48 |
Mettler-Toledo International Inc
MTD · USA
|
$29B |
90/100
Exzellent
|
45/100 |
60.0%low 60.0% |
10 yr+ |
— |
57% |
Mettler-Toledo International Inc. 价值投资深度研究29. Mai 2026 · 观察 |
FY2025 |